NCT00684723View on ClinicalTrials.gov

Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

Lovastatin 40 mg Tablets

40 mg tablet administered 30 minutes following the start of a standardized high-fat, high-calorie breakfast

DRUG

Lovastatin (Mevacor®) 40 mg Tablets

40 mg tablet administered 30 minutes following the start of a standardized high-fat, high-calorie breakfast

Trial Locations (1)

Unknown

Algorithme Pharma, Montreal

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00684723 - Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets | Biotech Hunter | Biotech Hunter